449 related articles for article (PubMed ID: 29709671)
1. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
[TBL] [Abstract][Full Text] [Related]
2. Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.
Ghebre MA; Bafadhel M; Desai D; Cohen SE; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Newby C; Burton PR; May RD; Brightling CE
J Allergy Clin Immunol; 2015 Jan; 135(1):63-72. PubMed ID: 25129678
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
5. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
6. Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup.
Diver S; Richardson M; Haldar K; Ghebre MA; Ramsheh MY; Bafadhel M; Desai D; Cohen ES; Newbold P; Rapley L; Rugman P; Pavord ID; May RD; Barer M; Brightling CE
Allergy; 2020 Apr; 75(4):808-817. PubMed ID: 31556120
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
8. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
9. Association of COPD exacerbation frequency with gene expression of pattern recognition receptors in inflammatory cells in induced sputum.
Kinose D; Ogawa E; Kudo M; Marumo S; Kiyokawa H; Hoshino Y; Hirai T; Chin K; Muro S; Mishima M
Clin Respir J; 2016 Jan; 10(1):11-21. PubMed ID: 24902764
[TBL] [Abstract][Full Text] [Related]
10. Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum.
Ghebre MA; Pang PH; Desai D; Hargadon B; Newby C; Woods J; Rapley L; Cohen SE; Herath A; Gaillard EA; May RD; Brightling CE
BMC Pulm Med; 2019 Aug; 19(1):144. PubMed ID: 31395050
[TBL] [Abstract][Full Text] [Related]
11. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
Bafadhel M; McCormick M; Saha S; McKenna S; Shelley M; Hargadon B; Mistry V; Reid C; Parker D; Dodson P; Jenkins M; Lloyd A; Rugman P; Newbold P; Brightling CE
Respiration; 2012; 83(1):36-44. PubMed ID: 21912093
[TBL] [Abstract][Full Text] [Related]
12. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
13. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
14. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation.
Daldegan MB; Teixeira MM; Talvani A
Braz J Med Biol Res; 2005 Sep; 38(9):1359-65. PubMed ID: 16138219
[TBL] [Abstract][Full Text] [Related]
15. Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD.
Paplińska-Goryca M; Nejman-Gryz P; Górska K; Białek-Gosk K; Hermanowicz-Salamon J; Krenke R
Adv Exp Med Biol; 2018; 1040():101-112. PubMed ID: 27739024
[TBL] [Abstract][Full Text] [Related]
16. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
17. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
18. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
[TBL] [Abstract][Full Text] [Related]
19. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.
Zhang M; Li Q; Zhang XY; Ding X; Zhu D; Zhou X
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1487-93. PubMed ID: 20725845
[TBL] [Abstract][Full Text] [Related]
20. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
